LUPRON DEPOT
Google image searchProduct monograph
Active ingredient
leuprolide acetate, 3.75 MG/SYR
DIN: 00884502
Dosage form(s): POWDER FOR SUSPENSION, SUSTAINED-RELEASE
Route(s) of administration: INTRAMUSCULAR
Description: PREFILLED SYRINGE
Schedule: Prescription
Company: ABBVIE CORPORATION
Date: 01-DEC-2013
ATC:
- L02 — ENDOCRINE THERAPY (ATC, ATC/DDD, )
- L02A — HORMONES AND RELATED AGENTS (ATC, ATC/DDD)
- L02AE — Gonadotropin releasing hormone analogues (ATC, ATC/DDD)
- L02AE02 — LEUPRORELIN (ATC/DDD)
Reference brand drug: Eligard, Lupron
Pharmaceutical standard: MFR
